高潤霖，1941年生，籍貫河北唐山，心血管病學(xué)家，中國醫(yī)學(xué)科學(xué)院阜外醫(yī)院研究員，博士生導(dǎo)師。1959年9月考入北京醫(yī)學(xué)院（現(xiàn)北大醫(yī)學(xué)部）醫(yī)學(xué)系，1965年8月畢業(yè)。1978年9月至 1981年12月在中國協(xié)和醫(yī)科大學(xué)（現(xiàn)北京協(xié)和醫(yī)學(xué)院）研究生院攻讀碩士學(xué)位，從事心血管病學(xué)研究。1985年9月至1986年8月在美國羅馬林達(dá)大學(xué)醫(yī)學(xué)院進(jìn)修介入心臟病學(xué)。1987年12月升為副研究員，1991年3月為研究員。1999年當(dāng)選為中國工程院院士。

我國介入心臟病學(xué)先驅(qū)，率先在國內(nèi)開展急性心肌梗死及并發(fā)心源性休克的急診介入治療和多項介入治療新技術(shù)，致力于介入治療再狹窄機制和預(yù)防研究，產(chǎn)學(xué)研結(jié)合，促進(jìn)藥物洗脫支架、可吸收藥物洗脫支架創(chuàng)新及國產(chǎn)化。

爆草黑丝美女|韩国19禁无遮挡啪啪无码网站|91精品国产自产精品男人的天堂|sm鞭打高潮喷水抽搐调教玩弄|果冻在线|日本大尺度吃奶呻吟视频|久久久久黄片|北条麻妃av免费观看|中文字幕一区二区人妻|亚洲最大天堂无码精品区,日韩 欧美 国产精品,国产肉丝袜在线观看,最爽无遮挡行房视频,成人H视频在线观看,糖心vlog冉冉,蜜桃产品一二三产区

1. Zheng JF#, Qiu H*, Tian Y, Hu XY, Luo T, Wu C, Tian Y, Tang Y, Song LF, Li L, Xu L, Xu B, and Gao RL*. Preclinical Evaluation of a Novel Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold in Porcine Coronary Artery at 6 Months. JACC Cardiovasc Interv. 2019;12(3):245-255.

2. Wang Z#*, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, Shao L, Tian Y, Dong Y, Zheng C, Wang J, Zhu M, Weintraub WS, Gao R*; China Hypertension Survey Investigators. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015. Circulation. 2018;137(22):2344-2356.

3. Tang Y#, Qiao S, Su X, Chen Y, Jin Z, Chen H, Xu B, Kong X, Pang W, Liu Y, Yu Z, Li X, Li H, Zhao Y, Wang Y, Li W, Tian J, Guan C, Xu B, and Gao R*; RESTORE SVD China Investigators. Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial. JACC Cardiovasc Interv. 2018;11(23):2381-2392.

4. Xu B#, Gao R*, Yang Y, Cao X, Qin L, Li Y, Li Z, Li X, Lin H, Guo Y, Ma Y, Wang J, Nie S, Xu L, Cao E, Guan C, Stone GW; PANDA III Investigators. Biodegradable Polymer-Based Sirolimus-Eluting Stents With Differing Elution and Absorption Kinetics: The PANDA III Trial. J Am Coll Cardiol. 2016;67(19):2249-2258.

5. Xu B#, Redfors B, Yang Y*, Qiao S, Wu Y, Chen J, Liu H, Chen J, Xu L, Zhao Y, Guan C, Gao R*, and Généreux P. Impact of Operator Experience and Volume on Outcomes After Left Main Coronary Artery Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2016;9(20):2086-2093.

6. Xu B#, Qian J, Ge J, Wang J, Chen F, Chen J, Wei M, Chen Y, Yang Y, Gao R*, PEPCAD China ISR investigators. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Catheter Cardiovasc Interv. 2016;87 Suppl 1:624-9.

7. Gao R#*, Yang Y, Han Y, Huo Y, Chen J, Yu B, Su X, Li L, Kuo HC, Ying SW, Cheong WF, Zhang Y, Su X, Xu B, Popma JJ, Stone GW; ABSORB China Investigators. Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial. J Am Coll Cardiol. 2015;66(21):2298-2309.

8. Xu B#, Gao R*, Wang J, Yang Y, Chen S, Liu B, Chen F, Li Z, Han Y, Fu G, Zhao Y, Ge J; PEPCAD China ISR Trial Investigators. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial. JACC Cardiovasc Interv. 2014;7(2):204-211.

9. Gao R#,Zhang J, Cheng L, Wu X, Dong W, Yang X, Li T, Liu X, Xu Y, Li X, and Zhou M*. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. J Am Coll Cardiol. 2010;55(18):1907-14.

10. Gao R#, Patel A, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Harris P, Algert C, Groenestein P, aTurnbull F*; CPACS Investigators. Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart. 2008;94(5):554-60.